Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS

This study confirms the diagnostic value of ApoA-I&II and identifies further potential diagnostic biomarkers for pancreatic cancer when multiple chip surfaces are used with depletion of the most highly-abundant proteins.